Ductal carcinoma in situ (DCIS) is a nonobligate precursor of invasive cancer, and its
detection, diagnosis, and management are controversial. DCIS incidence grew with the …

Several principles have been proposed to improve use of artificial intelligence (AI) in
healthcare, but the need for AI to improve longstanding healthcare challenges has not been …

Introduction Ductal carcinoma in situ (DCIS) is a non-invasive non-obligate precursor of
invasive breast cancer. With guideline concordant care (GCC), DCIS outcomes are at least …

A vast range of disorders—from indolent to fast-growing lesions—are labelled as cancer.
Therefore, we believe that several changes should be made to the approach to cancer …

Importance While the prevalence of ductal carcinoma in situ (DCIS) of the breast has
increased substantially following the introduction of breast-screening methods, the clinical …

Several important lessons have been learnt from our experiences in screening for various
cancers. Screening programmes for cervical and colorectal cancers have had the greatest …

Background The natural history of ductal carcinoma in situ (DCIS) remains uncertain. The
risk factors for the development of invasive cancer in unresected DCIS are unclear. Methods …

The original goal of mammographic screening was to identify invasive cancers at the earliest
stage, because of the superior prognosis of stage I cancers. Prior to the advent of screening …

Objective Assumptions on the natural history of ductal carcinoma in situ (DCIS) are
necessary to accurately model it and estimate overdiagnosis. To improve current estimates …

Background: Ductal carcinoma in situ (DCIS) is a noninvasive breast lesion with uncertain
risk for invasive progression. Usual care (UC) for DCIS consists of treatment upon diagnosis …